Detalhe da pesquisa
1.
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
Nature
; 592(7854): 450-456, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762733
2.
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient.
J Hepatol
; 80(5): 744-752, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218352
3.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972660
4.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Lancet Oncol
; 24(12): 1411-1422, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951222
5.
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension.
Clin Gastroenterol Hepatol
; 21(7): 1854-1863.e10, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36244661
6.
Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.
Clin Gastroenterol Hepatol
; 21(9): 2318-2326.e7, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842118
7.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology
; 76(4): 1000-1012, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313048
8.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int
; 43(3): 695-707, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577703
9.
A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade.
Proc Natl Acad Sci U S A
; 117(38): 23684-23694, 2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907939
10.
Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma.
J Cell Biochem
; 123(10): 1663-1673, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271841
11.
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
J Hepatol
; 76(5): 1090-1099, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066090
12.
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.
J Hepatol
; 76(4): 812-821, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871626
13.
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.
J Hepatol
; 76(2): 353-363, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648895
14.
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death.
Clin Gastroenterol Hepatol
; 20(6): 1362-1373.e6, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256145
15.
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension.
Clin Gastroenterol Hepatol
; 20(2): e251-e266, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33279774
16.
Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease.
Hepatology
; 73(4): 1275-1289, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32659847
17.
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease.
Liver Int
; 42(11): 2501-2512, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35822301
18.
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Liver Int
; 42(11): 2538-2547, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986902
19.
PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis.
EMBO Rep
; 21(12): e50893, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33225610
20.
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups.
Gut
; 70(1): 204-214, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747413